XML 58 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Earnings Per Share
 6 Months Ended
Dec. 27, 2014
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Six Months Ended
 
December 27,
2014
 
December 28,
2013
 
December 27,
2014
 
December 28,
2013
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
70.2

 
$
(86.0
)
 
$
166.5

 
$
25.3

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
136.3

 
98.7

 
135.1

 
96.4

Dilutive effect of share-based awards
0.5

 
—

 
0.5

 
0.5

Weighted average shares outstanding for diluted EPS
136.8

 
98.7

 
135.6

 
96.9

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS
0.2

 
0.2

 
0.1

 
0.1


Shareholders' Equity

Perrigo Company plc (formerly known as Perrigo Company Limited, and prior thereto, Blisfont Limited) was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant to Perrigo Company on December 18, 2013 in connection with the consummation of the Elan acquisition. Perrigo Company shares were canceled and exchanged for Perrigo Company plc shares on a one-for-one basis (together with the payment of $0.01 in cash per Perrigo Company share). All the remaining unsold shares of Perrigo Company were deregistered. Perrigo Company plc began trading on the New York Stock Exchange on December 19, 2013 and the Tel Aviv Stock Exchange on December 22, 2013 under the same symbol used by Perrigo Company ("PRGO") prior to December 18, 2013.

The Company issued 40 thousand and 70 thousand shares related to the exercise and vesting of share-based compensation during the three months ended December 27, 2014 and December 28, 2013, respectively. The Company issued 226 thousand and 334 thousand shares related to the exercise and vesting of share-based compensation during six months ended December 27, 2014 and December 28, 2013, respectively.

In addition, to partially finance the pending Omega acquisition, the Company issued 6,809,210 ordinary shares at $152.00 per share in a public offering that closed on November 26, 2014. The offering raised approximately $1.0 billion, offset by $35.7 million of issuance costs.

The Company does not currently have an ordinary share repurchase program.